CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
This Quarter Return
+13.96%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$705M
AUM Growth
+$705M
(+6.2%)
Cap. Flow
+$13.9M
Cap. Flow
% of AUM
1.97%
Top 10 Holdings %
Top 10 Hldgs %
40.32%
Holding
99
New
15
Increased
52
Reduced
12
Closed
16
Top Buys
| 1 |
Theravance Biopharma
TBPH
|
$25.4M |
| 2 |
Galapagos
GLPG
|
$18.3M |
| 3 |
Clearside Biomedical
CLSD
|
$13.9M |
| 4 |
Minerva Neurosciences
NERV
|
$10.7M |
| 5 |
RLYP
RELYPSA INC COM
RLYP
|
$8.33M |
Top Sells
| 1 |
Alkermes
ALKS
|
$23.9M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$10.6M |
| 3 |
CELG
Celgene Corp
CELG
|
$10M |
| 4 |
Neurocrine Biosciences
NBIX
|
$9.34M |
| 5 |
Rockwell Medical
RMTI
|
$8.3M |
Sector Composition
| 1 | Healthcare | 87.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALDR
1
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $42.2M | 5.98% | 1,689,071 +191,596 | +13% | +$4.78M |
|
|
NVRO
2
DELISTED
NEVRO CORP.
NVRO
| $36.2M | 5.14% | 491,044 +5,658 | +1% | +$417K |
|
3
Heron Therapeutics
HRTX
$207M
| $32M | 4.53% | 1,771,263 +21,263 | +1% | +$384K |
|
|
TSRO
4
DELISTED
TESARO, Inc.
TSRO
| $30.5M | 4.33% | 362,875 +71,625 | +25% | +$6.02M |
|
5
Nektar Therapeutics
NKTR
$568M
| $28.8M | 4.08% | 2,022,879 +22,879 | +1% | +$326K |
|
|
6
Minerva Neurosciences
NERV
$16.5M
| $28.6M | 4.05% | 2,800,000 +1,047,054 | +60% | +$10.7M |
|
|
7
Theravance Biopharma
TBPH
$699M
| $25.4M | 3.6% | +1,118,372 | New | +$25.4M |
|
|
SAGE
8
DELISTED
Sage Therapeutics
SAGE
| $22M | 3.12% | 730,000 -215,000 | -23% | -$6.48M |
|
|
EGRX
9
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $19.6M | 2.78% | 505,995 +5,995 | +1% | +$233K |
|
10
MacroGenics
MGNX
$112M
| $19.1M | 2.71% | 707,978 +7,978 | +1% | +$215K |
|
|
VTAE
11
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $18.9M | 2.69% | 1,754,795 +19,795 | +1% | +$214K |
|
|
12
Galapagos
GLPG
$2.07B
| $18.3M | 2.6% | +334,044 | New | +$18.3M |
|
|
13
Neurocrine Biosciences
NBIX
$13.8B
| $18.1M | 2.57% | 398,301 -205,599 | -34% | -$9.34M |
|
14
Omeros
OMER
$283M
| $18M | 2.55% | 1,710,000 -250,000 | -13% | -$2.63M |
|
15
Aclaris Therapeutics
ACRS
$209M
| $16.6M | 2.36% | 901,286 +253,342 | +39% | +$4.68M |
|
|
KA
16
DELISTED
Kineta, Inc. Common Stock
KA
| $16.4M | 2.33% | 1,354,339 -372,260 | -22% | -$4.52M |
|
|
17
Clearside Biomedical
CLSD
$28.9M
| $13.9M | 1.98% | +1,988,208 | New | +$13.9M |
|
|
CLLS
18
Cellectis
CLLS
$258M
| $13.2M | 1.88% | 498,117 +28,972 | +6% | +$770K |
|
19
Ardelyx
ARDX
$1.53B
| $13.1M | 1.86% | 1,499,226 +18,151 | +1% | +$158K |
|
|
CBPO
20
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $12M | 1.7% | 112,867 +1,367 | +1% | +$145K |
|
|
QTNT
21
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $11.9M | 1.69% | 1,537,717 +18,617 | +1% | +$144K |
|
|
SRNE
22
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $11.9M | 1.68% | 2,121,013 +25,679 | +1% | +$144K |
|
23
Novavax
NVAX
$1.21B
| $11.8M | 1.67% | 1,619,608 +19,608 | +1% | +$143K |
|
24
Alnylam Pharmaceuticals
ALNY
$58.5B
| $11.1M | 1.58% | 200,355 -44,645 | -18% | -$2.48M |
|
25
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $9.73M | 1.38% | 576,106 +6,976 | +1% | +$118K |
|